Skip navigation
Speakers

Critical Updates and a Roadmap for New and Proposed Changes

June 19-20, 2019
  • Alexandria, VA

Mike Anderson
Chief Executive Officer, Part D
UnitedHealthcare

Alison Anway
Principal
Anway Long Group

Nicole Braccio, PharmD
Policy Director
National Patient Advocate Foundation

Michael Eging
Executive Director
Rare Access Action Project

Robert Falb
Director, U.S. Policy & Advocacy
Alliance for Regenerative Medicine

Katie Holcomb, FSA, MAAA
Consulting Actuary
Milliman

Douglas Holtz-Eakin
President
American Action Forum

Terrill Jordan
President and CEO
Regional Cancer Care Associates

Arielle Kane
Director of Health Care
Progressive Policy Institute

Lisa Kennedy, PhD
Managing Principal
Innopiphany LLC

David Mike, FSA, MAAA
Consulting Actuary
Milliman

Tara O’Neill Hayes
Deputy Director, Health Care Policy
American Action Forum

J.P. Paluskiewicz
Chief Minority Health Counsel, Energy & Commerce Committee
US House of Representatives

Robert Popovian, PharmD, MS
Vice President, U.S. Government Relations
Pfizer Inc

Surya Singh, MD
President, Singh Healthcare Advisors, LLC;
former VP/CMO, CVS Health Specialty

Milena Sullivan
Principal
Avalere Health

Abe Sutton
Health Advisor at Domestic Policy Council
The White House

Wayne Winegarden, PhD
Senior Fellow
Pacific Research Institute

James Wu, M.Sc., M.P.H.
Principal Health Economist, HTA Center of Excellence
Amgen, Inc.

Mike Anderson
Chief Executive Officer, Part D
UnitedHealthcare

Alison Anway
Principal
Anway Long Group

Nicole Braccio, PharmD
Policy Director
National Patient Advocate Foundation

Michael Eging
Executive Director
Rare Access Action Project

Robert Falb
Director, U.S. Policy & Advocacy
Alliance for Regenerative Medicine

Katie Holcomb, FSA, MAAA
Consulting Actuary
Milliman

Douglas Holtz-Eakin
President
American Action Forum

Terrill Jordan
President and CEO
Regional Cancer Care Associates

Arielle Kane
Director of Health Care
Progressive Policy Institute

Lisa Kennedy, PhD
Managing Principal
Innopiphany LLC

David Mike, FSA, MAAA
Consulting Actuary
Milliman

Tara O’Neill Hayes
Deputy Director, Health Care Policy
American Action Forum

J.P. Paluskiewicz
Chief Minority Health Counsel, Energy & Commerce Committee
US House of Representatives

Robert Popovian, PharmD, MS
Vice President, U.S. Government Relations
Pfizer Inc

Surya Singh, MD
President, Singh Healthcare Advisors, LLC;
former VP/CMO, CVS Health Specialty

Milena Sullivan
Principal
Avalere Health

Abe Sutton
Health Advisor at Domestic Policy Council
The White House

Wayne Winegarden, PhD
Senior Fellow
Pacific Research Institute

James Wu, M.Sc., M.P.H.
Principal Health Economist, HTA Center of Excellence
Amgen, Inc.